title: [GIST: Imaging diagnosis, staging, and response assessment].
abstract: Diagnosis of gastrointestinal stromal tumors (GIST), which are located in the stomach or colon, is a domain of endoscopy. For midgut GIST is contrast-enhanced multidetector-CT the standard imaging technique. With the development of enteroclysis - MDCT better distension of the small bowel can be achieved to find even small tumors in the bowel wall. For staging of GIST is contrast-enhanced MDCT of the abdomen (and chest) recommended, unless PET/CT is widely available. Contrast-enhanced MRI is used for local staging of rectal tumors and as a problem-solving tool in patients with equivocal lesions at CT of the liver. In chemotherapy-responders, metastases may undergo necrosis and liquefaction with shrinkage. Therefore the RECIST criteria have been found to be unreliable to assess tumor response. The modified CT response criteria of Choi et al. have been developed and validated for more accurate assessment of chemotherapy. If available, is FDG-PET/CT the modality of choice for the follow-up of GIST patients at risk of metastases.
authors.affiliation: Abteilung für Radiologie und bildgebende Diagnostik, Krankenhaus Göttlicher Heiland, Wien, Austria. wolfgang.schima@khgh.at
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Schima
authors.forename: Amir
authors.initials: A
authors.lastname: Kurtaran
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D001706:Biopsy; D003110:Colonic Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D003287:Contrast Media / Q000008:administration & dosage; D005500:Follow-Up Studies; D046152:Gastrointestinal Stromal Tumors / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000556:secondary; D006801:Humans; D007091:Image Processing, Computer-Assisted; D000068877:Imatinib Mesylate; D008113:Liver Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000556:secondary; D009367:Neoplasm Staging; D010879:Piperazines / Q000627:therapeutic use; D049268:Positron-Emission Tomography; D011743:Pyrimidines / Q000627:therapeutic use; D012680:Sensitivity and Specificity; D013274:Stomach Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D036542:Tomography, Spiral Computed
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D003287:Contrast Media; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate
references.citation: Ann Oncol. 2008 May;19 Suppl 2:ii35-8
references.pmid: 18456761
references.citation: J Comput Assist Tomogr. 2000 Mar-Apr;24(2):224-8
references.pmid: 10752882
references.citation: Eur J Nucl Med Mol Imaging. 2005 Feb;32(2):153-62
references.pmid: 15690223
references.citation: Radiology. 1998 Sep;208(3):591-5
references.pmid: 9722833
references.citation: J Clin Oncol. 2007 May 1;25(13):1753-9
references.pmid: 17470865
references.citation: Eur Radiol. 2003 Jul;13(7):1669-78
references.pmid: 12835984
references.citation: Oncologist. 2008;13 Suppl 2:8-13
references.pmid: 18434632
references.citation: Radiology. 2005 Jun;235(3):892-8
references.pmid: 15833985
references.citation: Radiographics. 2003 Mar-Apr;23(2):283-304, 456; quiz 532
references.pmid: 12640147
references.citation: Rofo. 2000 Mar;172(3):287-94
references.pmid: 10778462
references.citation: AJR Am J Roentgenol. 2004 Dec;183(6):1619-28
references.pmid: 15547201
references.citation: Eur J Radiol. 2009 Feb;69(2):204-8
references.pmid: 19046841
references.citation: Ann Surg. 2000 Jan;231(1):51-8
references.pmid: 10636102
references.citation: Radiology. 2003 Feb;226(2):527-32
references.pmid: 12563150
references.citation: Ann Oncol. 2005 Apr;16(4):566-78
references.pmid: 15781488
references.citation: J Gastrointestin Liver Dis. 2007 Jun;16(2):147-51
references.pmid: 17592560
references.citation: Oncologist. 2008;13 Suppl 2:4-7
references.pmid: 18434631
references.citation: J Nucl Med. 2004 Mar;45(3):357-65
references.pmid: 15001674